Oil & Gas Midstream
Compare Stocks
5 / 10Stock Comparison
RBNE vs PESI vs GEVO vs CLNE vs HYLN
Revenue, margins, valuation, and 5-year total return — side by side.
Waste Management
Chemicals - Specialty
Oil & Gas Refining & Marketing
Auto - Parts
RBNE vs PESI vs GEVO vs CLNE vs HYLN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Midstream | Waste Management | Chemicals - Specialty | Oil & Gas Refining & Marketing | Auto - Parts |
| Market Cap | $4M | $204M | $444M | $485M | $462M |
| Revenue (TTM) | $7M | $59M | $174M | $439M | $3M |
| Net Income (TTM) | $1M | $-18M | $-12M | $-99M | $-57M |
| Gross Margin | 78.1% | 4.1% | 34.3% | 11.7% | 4.9% |
| Operating Margin | 15.8% | -26.3% | -4.6% | 7.4% | -18.9% |
| Forward P/E | 3.0x | — | — | — | — |
| Total Debt | $0.00 | $4M | $168M | $99M | $4M |
| Cash & Equiv. | $369.00 | $12M | $1M | $158M | $23M |
RBNE vs PESI vs GEVO vs CLNE vs HYLN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 25 | May 26 | Return |
|---|---|---|---|
| Robin Energy Ltd. (RBNE) | 100 | 48.2 | -51.8% |
| Perma-Fix Environme… (PESI) | 100 | 134.1 | +34.1% |
| Gevo, Inc. (GEVO) | 100 | 166.4 | +66.4% |
| Clean Energy Fuels … (CLNE) | 100 | 152.4 | +52.4% |
| Hyliion Holdings Co… (HYLN) | 100 | 162.9 | +62.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RBNE vs PESI vs GEVO vs CLNE vs HYLN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RBNE carries the broadest edge in this set and is the clearest fit for value and quality.
- Better valuation composite
- 15.5% margin vs HYLN's -16.5%
- 4.3% ROA vs HYLN's -28.1%, ROIC 3.3% vs -23.7%
PESI is the clearest fit if your priority is long-term compounding.
- 174.4% 10Y total return vs CLNE's -30.1%
GEVO is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs RBNE's -56.6%
- +60.5% vs RBNE's -53.9%
CLNE ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- beta 1.04
- Lower volatility, beta 1.04, Low D/E 17.5%, current ratio 2.32x
- Beta 1.04, current ratio 2.32x
- Beta 1.04 vs HYLN's 2.34
Among these 5 stocks, HYLN doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs RBNE's -56.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 15.5% margin vs HYLN's -16.5% | |
| Stability / Safety | Beta 1.04 vs HYLN's 2.34 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +60.5% vs RBNE's -53.9% | |
| Efficiency (ROA) | 4.3% ROA vs HYLN's -28.1%, ROIC 3.3% vs -23.7% |
RBNE vs PESI vs GEVO vs CLNE vs HYLN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
RBNE vs PESI vs GEVO vs CLNE vs HYLN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RBNE leads in 3 of 6 categories
GEVO leads 1 • PESI leads 0 • CLNE leads 0 • HYLN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RBNE leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLNE is the larger business by revenue, generating $439M annually — 126.3x HYLN's $3M. RBNE is the more profitable business, keeping 15.5% of every revenue dollar as net income compared to HYLN's -16.5%. On growth, RBNE holds the edge at +151.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7M | $59M | $174M | $439M | $3M |
| EBITDAEarnings before interest/tax | — | -$14M | $21M | $62M | -$60M |
| Net IncomeAfter-tax profit | — | -$18M | -$12M | -$99M | -$57M |
| Free Cash FlowCash after capex | — | -$13M | -$35M | $19M | -$70M |
| Gross MarginGross profit ÷ Revenue | +78.1% | +4.1% | +34.3% | +11.7% | +4.9% |
| Operating MarginEBIT ÷ Revenue | +15.8% | -26.3% | -4.6% | +7.4% | -18.9% |
| Net MarginNet income ÷ Revenue | +15.5% | -30.1% | -6.7% | -22.7% | -16.5% |
| FCF MarginFCF ÷ Revenue | +100.8% | -22.0% | -19.9% | +4.3% | -20.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +151.6% | -20.1% | +47.5% | +13.3% | -52.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +118.5% | -110.5% | +3.8% | +90.0% | +12.5% |
Valuation Metrics
RBNE leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, RBNE's 1.6x EV/EBITDA is more attractive than GEVO's 94.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4M | $204M | $444M | $485M | $462M |
| Enterprise ValueMkt cap + debt − cash | $4M | $197M | $611M | $426M | $444M |
| Trailing P/EPrice ÷ TTM EPS | 2.98x | -14.67x | -13.07x | -2.19x | -7.45x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 1.64x | — | 94.60x | 90.01x | — |
| Price / SalesMarket cap ÷ Revenue | 0.54x | 3.31x | 2.77x | 1.14x | 133.00x |
| Price / BookPrice ÷ Book value/share | 0.15x | 4.05x | 0.91x | 0.86x | 2.25x |
| Price / FCFMarket cap ÷ FCF | 0.54x | — | — | 8.10x | — |
Profitability & Efficiency
RBNE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
RBNE delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-34 for PESI. HYLN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEVO's 0.36x. On the Piotroski fundamental quality scale (0–9), RBNE scores 5/9 vs HYLN's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.4% | -34.5% | -2.5% | -17.2% | -29.8% |
| ROA (TTM)Return on assets | +4.3% | -20.2% | -1.7% | -9.2% | -28.1% |
| ROICReturn on invested capital | +3.3% | -21.7% | -2.8% | -9.4% | -23.7% |
| ROCEReturn on capital employed | +4.4% | -16.7% | -3.1% | -9.4% | -29.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 4 | 5 | 4 |
| Debt / EquityFinancial leverage | — | 0.09x | 0.36x | 0.18x | 0.02x |
| Net DebtTotal debt minus cash | -$369 | -$7M | $166M | -$59M | -$19M |
| Cash & Equiv.Liquid assets | $369 | $12M | $1M | $158M | $23M |
| Total DebtShort + long-term debt | $0 | $4M | $168M | $99M | $4M |
| Interest CoverageEBIT ÷ Interest expense | 81.61x | -42.14x | 0.37x | -1.07x | — |
Total Returns (Dividends Reinvested)
GEVO leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PESI five years ago would be worth $14,667 today (with dividends reinvested), compared to $1,541 for RBNE. Over the past 12 months, GEVO leads with a +60.5% total return vs RBNE's -53.9%. The 3-year compound annual growth rate (CAGR) favors GEVO at 14.2% vs RBNE's -46.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -58.8% | -10.2% | -11.2% | +2.3% | +35.2% |
| 1-Year ReturnPast 12 months | -53.9% | +15.8% | +60.5% | +29.2% | +47.3% |
| 3-Year ReturnCumulative with dividends | -84.6% | +19.8% | +48.8% | -48.6% | +39.8% |
| 5-Year ReturnCumulative with dividends | -84.6% | +46.7% | -65.8% | -74.8% | -70.4% |
| 10-Year ReturnCumulative with dividends | -84.6% | +174.4% | -98.7% | -30.1% | -74.6% |
| CAGR (3Y)Annualised 3-year return | -46.4% | +6.2% | +14.2% | -19.9% | +11.8% |
Risk & Volatility
Evenly matched — RBNE and HYLN each lead in 1 of 2 comparable metrics.
Risk & Volatility
RBNE is the less volatile stock with a -0.47 beta — it tends to amplify market swings less than HYLN's 2.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HYLN currently trades 96.1% from its 52-week high vs RBNE's 6.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.47x | 1.74x | 1.55x | 1.04x | 2.34x |
| 52-Week HighHighest price in past year | $20.57 | $16.50 | $2.97 | $3.11 | $2.56 |
| 52-Week LowLowest price in past year | $0.67 | $8.02 | $1.07 | $1.60 | $1.11 |
| % of 52W HighCurrent price vs 52-week peak | +6.4% | +66.7% | +61.6% | +71.1% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 34.0 | 35.7 | 52.1 | 49.0 | 75.5 |
| Avg Volume (50D)Average daily shares traded | 6.5M | 164K | 4.6M | 1.4M | 950K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: PESI as "Hold", GEVO as "Buy", CLNE as "Buy", HYLN as "Hold". Consensus price targets imply 91.3% upside for GEVO (target: $4) vs 27.2% for HYLN (target: $3).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $18.00 | $3.50 | $3.50 | $3.13 |
| # AnalystsCovering analysts | — | 1 | 14 | 22 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +1.6% | 0.0% |
RBNE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). GEVO leads in 1 (Total Returns). 1 tied.
RBNE vs PESI vs GEVO vs CLNE vs HYLN: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is RBNE or PESI or GEVO or CLNE or HYLN a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -56. 6% for Robin Energy Ltd. (RBNE). Robin Energy Ltd. (RBNE) offers the better valuation at 3. 0x trailing P/E, making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — RBNE or PESI or GEVO or CLNE or HYLN?
Over the past 5 years, Perma-Fix Environmental Services, Inc.
(PESI) delivered a total return of +46. 7%, compared to -84. 6% for Robin Energy Ltd. (RBNE). Over 10 years, the gap is even starker: PESI returned +174. 4% versus GEVO's -98. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — RBNE or PESI or GEVO or CLNE or HYLN?
By beta (market sensitivity over 5 years), Robin Energy Ltd.
(RBNE) is the lower-risk stock at -0. 47β versus Hyliion Holdings Corp. 's 2. 34β — meaning HYLN is approximately -601% more volatile than RBNE relative to the S&P 500. On balance sheet safety, Hyliion Holdings Corp. (HYLN) carries a lower debt/equity ratio of 2% versus 36% for Gevo, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — RBNE or PESI or GEVO or CLNE or HYLN?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -56. 6% for Robin Energy Ltd. (RBNE). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — RBNE or PESI or GEVO or CLNE or HYLN?
Robin Energy Ltd.
(RBNE) is the more profitable company, earning 15. 5% net margin versus -1645. 7% for Hyliion Holdings Corp. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RBNE leads at 15. 8% versus -1886. 4% for HYLN. At the gross margin level — before operating expenses — RBNE leads at 78. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — RBNE or PESI or GEVO or CLNE or HYLN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is RBNE or PESI or GEVO or CLNE or HYLN better for a retirement portfolio?
For long-horizon retirement investors, Robin Energy Ltd.
(RBNE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 47)). Hyliion Holdings Corp. (HYLN) carries a higher beta of 2. 34 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RBNE: -84. 6%, HYLN: -74. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between RBNE and PESI and GEVO and CLNE and HYLN?
These companies operate in different sectors (RBNE (Energy) and PESI (Industrials) and GEVO (Basic Materials) and CLNE (Energy) and HYLN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RBNE is a small-cap deep-value stock; PESI is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock; CLNE is a small-cap quality compounder stock; HYLN is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.